Immunological Medicines for Poultry
Immunological veterinary medicinal products, including vaccines, are authorised for poultry.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Avinew
|
Newcastle-Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.02053.01.1 |
05.03.2002 |
Huhn |
PharmNet.Bund
|
Avinew NEO
|
Newcastle-Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.02053.02.1 |
30.07.2020 |
Huhn, Pute |
PharmNet.Bund
|
AviPro AE
|
Aviäre Encephalomyelitis
|
Lohmann Animal Health GmbH
|
94a/89 |
20.07.1999 |
Huhn |
PharmNet.Bund
|
AviPro GUMBORO VAC
|
Infektiöse Bursitis
|
Lohmann Animal Health GmbH
|
87a/78 |
27.02.1998 |
Huhn |
PharmNet.Bund
|
AviPro IB H120
|
Infektiöse Bronchitis
|
Lohmann Animal Health GmbH
|
A13/79 |
02.02.2001 |
Huhn |
PharmNet.Bund
|
AviPro IB-ND C131
|
Infektiöse Bronchitis, Newcastle-Krankheit
|
Elanco GmbH
|
PEI.V.12115.01.1 |
19.07.2023 |
Huhn |
|
AviPro IBD Xtreme
|
Infektiöse Bursitis
|
Lohmann Animal Health GmbH
|
PEI.V.03418.01.1 |
27.02.2008 |
Huhn |
PharmNet.Bund
|
AviPro ND C131
|
Newcastle-Krankheit
|
Lohmann Animal Health GmbH
|
PEI.V.03159.02.1 |
17.07.2017 |
Huhn, Pute |
|
AviPro ND LASOTA
|
Newcastle-Krankheit
|
Lohmann Animal Health GmbH
|
200a/97 |
27.10.1998 |
Huhn, Pute |
PharmNet.Bund
|
AviPro PRECISE
|
Infektiöse Bursitis
|
Lohmann Animal Health GmbH
|
571a/91 |
09.03.1998 |
Masthuhn |
PharmNet.Bund
|
AviPro SALMONELLA DUO
|
Salmonellen-Infektion
|
Lohmann Animal Health GmbH
|
PEI.V.11469.02.1 |
08.04.2014 |
Ente, Huhn, Pute |
PharmNet.Bund
|
AviPro SALMONELLA VAC E
|
Salmonellen-Infektion
|
Lohmann Animal Health GmbH
|
85a/97 |
21.07.1999 |
Huhn |
PharmNet.Bund
|
AviPro Salmonella vac T
|
Salmonellen-Infektion
|
Lohmann Animal Health GmbH
|
252a/93 |
15.06.1994 |
Huhn |
PharmNet.Bund
|
AviPro THYMOVAC
|
Hühner-Anämie
|
Lohmann Animal Health GmbH
|
220a/88 |
14.06.1999 |
Huhn |
PharmNet.Bund
|
Avishield IB GI-13
|
Infektiöse Bronchitis
|
GENERA Inc., Kroatien
|
PEI.V.11998.01.1 |
27.03.2020 |
Huhn |
PharmNet.Bund
|
Avishield IB H120
|
Infektiöse Bronchitis
|
GENERA Inc., Kroatien
|
PEI.V.11899.01.1 |
02.03.2018 |
Huhn |
PharmNet.Bund
|
Avishield IBD INT
|
Infektiöse Bursitis
|
GENERA Inc., Kroatien
|
PEI.V.11956.01.1 |
15.02.2019 |
Huhn |
PharmNet.Bund
|
Avishield IBD Plus
|
Infektiöse Bursitis
|
Genera Inc., Kroatien
|
PEI.V.12013.01.1 |
30.06.2020 |
Huhn |
PharmNet.Bund
|
Avishield ND
|
Newcastle-Krankheit
|
GENERA Inc., Kroatien
|
PEI.V.11742.01.1 |
08.04.2016 |
Huhn, Pute |
PharmNet.Bund
|
Avishield ND B1
|
Newcastle-Krankheit
|
GENERA Inc., Kroatien
|
PEI.V.11928.01.1 |
06.04.2018 |
Huhn, Pute |
PharmNet.Bund
|
CEVAC IBird
|
Infektiöse Bronchitis
|
Ceva Tiergesundheit GmbH
|
PEI.V.11646.01.1 |
20.06.2013 |
Huhn |
PharmNet.Bund
|
CEVAC MASS L
|
Infektiöse Bronchitis
|
Ceva Tiergesundheit GmbH
|
PEI.V.11823.01.1 |
04.04.2016 |
Huhn |
PharmNet.Bund
|
Cevac MD Rispens
|
Marek'sche Krankheit
|
Ceva Tiergesundheit GmbH
|
PEI.V.11975.01.1 |
31.07.2020 |
Huhn |
|
Cevac Meta L
|
Aviäre Rhinotracheitis
|
Ceva Tiergesundheit GmbH
|
PEI.V.11806.01.1 |
31.10.2016 |
Huhn |
PharmNet.Bund
|
Cevac Salmovac
|
Salmonellen-Infektion
|
Ceva Tiergesundheit GmbH
|
PEI.V.02823.01.1 |
07.11.2002 |
Huhn |
PharmNet.Bund
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.